News und Analysen
Mola.tv transformiert Digital Rights Management in die Verimatrix Secure Cloud
Verimatrix, (Paris:VMX), ehemals bekannt als Inside Secure, ein globaler Anbieter von innovativen, kundenfreundlichen Cybersicherheitslösungen zum Schutz von Videoinhalten, Endgeräten, Software und
Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST
Regulatory News:
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on
Mola.tv Takes Digital Rights Management into the Verimatrix Secure Cloud
Regulatory News:
Verimatrix, (Paris:VMX), formerly known as Inside Secure, a global provider of innovative, customer-friendly cybersecurity solutions that protect video content, endpoint devices
Albaniens größter Videodienstanbieter TiBO setzt Verimatrix Multi-DRM für die Verwaltung Cloud-basierter digitaler Rechte ein
Regulatorische Meldungen:
Verimatrix, (Paris:VMX) (Euronext Paris: VMX), ehemals bekannt als Inside Secure, ein globaler Anbieter von innovativen, kundenfreundlichen Cybersicherheitslösungen zum
Albania’s Largest Video Service Provider TiBO Deploys Verimatrix Multi-DRM For Cloud-based Digital Rights Management
Regulatory News:
Verimatrix, (Paris:VMX) (Euronext Paris: VMX), formerly known as Inside Secure, a global provider of innovative, customer-friendly cybersecurity solutions that protect video
Verimatrix und Qt Company präsentieren gemeinsam IoT-Shielding auf der Embedded World 2020
Verimatrix, vormals bekannt als Inside Secure, ein global tätiger Anbieter von innovativen, kundenfreundlichen Cyber-Sicherheitslösungen zum Schutz von Video-Inhalten, Endgeräten, Software und
Verimatrix and Qt Company Join Forces at Embedded World 2020 to Showcase IoT Shielding
Verimatrix, (Paris:VMX), formerly known as Inside Secure, a global provider of innovative, customer-friendly cybersecurity solutions that protect video content, endpoint devices, software and
First Patient Dosed With Transgene’s Oncolytic Virus TG6002, Administered by Intrahepatic Artery Infusion in Colorectal Cancer With Liver Metastases
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that the first
Cellectis and Servier Expand Collaboration on UCART19 Products
Regulatory News:
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic
ESI Group: Full-Year 2019 Sales
Regulatory News:
ESI Group, Paris, France, (ISIN Code: FR0004110310, Symbol: ESI) (Paris:ESI), releases its sales for the financial year starting on February 1, 2019 and ending on December 31
MEDICREA® Announces FDA Clearance of the World’s First Patient-Matched Spinal Interbody Cages
MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
NANOBIOTIX Announces Fast Track Designation Granted By U.S. FDA For Investigation of First-in-class NBTXR3 In Head and Neck Cancer
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext: NANO - ISIN: FR0011341205 – the “Company”), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today
MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spine Surgery Milestone With Strong Penetration of the Degenerative and Minimally Invasive Market Segment
MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
Carbios Enters Joint Development Agreement With Novozymes to Produce Its Proprietary Enzyme for Complete Recycling of PET-plastics and Fibers
Regulatory News:
CARBIOS (Euronext Growth Paris: ALCRB), a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, announced today an exclusive
Carbios kündigt strategische Allianz mit dem Nationalen Institut für angewandte Wissenschaften von Toulouse (INSA) an
CARBIOS (Paris:ALCRB) (Euronext Growth Paris: ALCRB), ein französisches Unternehmen aus dem Bereich grüne Chemie mit Sitz in Clermont-Ferrand, gab heute eine strategische Allianz mit dem INSA
Carbios Announces Strategic Alliance with the National Institute of Applied Sciences of Toulouse (INSA)
Regulatory News:
CARBIOS (Paris:ALCRB) (Euronext Growth Paris: ALCRB), a French green chemistry company based in Clermont-Ferrand, announced today a strategic alliance with INSA Toulouse through
First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia
Regulatory News:
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on
MEDICREA® Reports 2019 Annual Sales
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA Announces Preliminary Discussions With U.S. Strategic Partners
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
AKKA Launches a Recommended Voluntary Cash Offer on Data Respons ASA at NOK 48 Per Share
Regulatory News:
Following the announcement on 19 December 2019 to acquire Data Respons, AKKA Technologies SE (Paris:AKA) (BSE:AKA) (ISIN:FR0004180537), European leader in digital engineering
NANOBIOTIX Announces Plan for Global Phase III Head and Neck Cancer Registration Trial Along With Overall Development Update
Regulatory News:
“After the achievement of major development milestones in 2019, 2020 offers great opportunity for Nanobiotix and NBTXR3 to fulfill unmet patient needs across oncology. Given
Farasis Energy gelingt mit Virtual Prototyping von ESI der Durchbruch auf dem Elektrofahrzeugmarkt
Die ESI Group (Paris:ESI), führender Innovator rund um Virtual Prototyping Software und Services für die Fertigungsindustrie, hat den chinesisch-amerikanischen Batteriehersteller Farasis Energy
Farasis Energy Breaks Through the Electric Vehicle Market Thanks to ESI’s Virtual Prototyping
ESI Group (Paris:ESI), leading innovator in Virtual Prototyping
software and services for manufacturing industries, helped Farasis
Energy, a Chinese-American battery provider,
Transgene and NEC Start Two Clinical Trials with TG4050, an Individualized AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE:
Cellectis: An Expert Review on Allogeneic CAR-T for Cancer Published in Nature Reviews Drug Discovery
Cellectis
(Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth:ALCLS; Nasdaq:CLLS), a
biopharmaceutical company focused on developing immunotherapies based on
gene-edited